Aphria Inc. produces, supplies, and sells medical cannabis in Canada. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It also provides support services in the form of medical consultations, group therapies, and rehabilitation to veteran and first responders. The company sells its products through its online store or phones, as well as engages in the wholesale shipping of medical marijuana plant cuttings and dried buds to other licensed producers. Aphria Inc. is headquartered in Leamington, Canada.
Industry, Sector and Symbol
Stock Exchange TSE
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
SymbolTSE:APH
CUSIPN/A
PhoneN/A
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins75.91%
Return on Equity7.63%
Return on Assets6.72%
Miscellaneous
EmployeesN/A
Outstanding Shares203,966,000
Market CapC$2,310.00
Aphria (TSE:APH) Frequently Asked Questions
What is Aphria's stock symbol?
Aphria trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APH."
When is Aphria's next earnings date?
What price target have analysts set for APH?
0 analysts have issued twelve-month price targets for Aphria's shares. Their predictions range from C$24.50 to C$25.00. On average, they expect Aphria's stock price to reach C$24.75 in the next year. This suggests a possible upside of 122.0% from the stock's current price. View Analyst Ratings for Aphria.
What is the consensus analysts' recommendation for Aphria?
0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."
Who are some of Aphria's key competitors?
Some companies that are related to Aphria include Valeant Pharmaceuticals Intl (VRX), Canopy Growth (WEED), Aurora Cannabis (ACB), STADA Arzneimittel (SAZ), Hikma Pharmaceuticals (HKMPY), Hikma Pharmaceuticals (HIK), MedReleaf (LEAF), Knight Therapeutics (KHTRF), Hydropothecary (THCX), OrganiGram (OGI), Supreme Cannabis (FIRE), Weed (BUDZ), OrganiGram (OGRMF), Medical Marijuana (MJNA) and Benchmark (BMK).
Who are Aphria's key executives?
Aphria's management team includes the folowing people:
- Mr. Victor Neufeld, Chair of the Board of Directors, CEO & Pres (Age 64)
- Mr. Cole Cacciavillani, Co-Founder, COO, VP of Growing Operations & Director (Age 63)
- Mr. John Cervini, Co-Founder, Chief Agronomist Officer, VP of Infrastructure & Technology and Director
- Mr. Carl A. Merton, Chief Financial Officer
- Ms. Megan McCrae, Director of Marketing
Has Aphria been receiving favorable news coverage?
News articles about APH stock have trended somewhat positive on Monday, Accern reports. The research group rates the sentiment of news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Aphria earned a media sentiment score of 0.15 on Accern's scale. They also gave media headlines about the company an impact score of 48.83 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.
How do I buy shares of Aphria?
Shares of APH and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Aphria's stock price today?
One share of APH stock can currently be purchased for approximately C$11.15.
How big of a company is Aphria?
Aphria has a market capitalization of C$2.31 billion.
MarketBeat Community Rating for Aphria (TSE APH)
MarketBeat's community ratings are surveys of what our community members think about Aphria and other stocks. Vote "Outperform" if you believe APH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APH will underperform the S&P 500 over the long term. You may vote once every thirty days.
